Dechra, a global leader in veterinary specialty care, today announced the U.S. launch of Domidine™ (detomidine hydrochloride), a trusted, effective equine sedative and analgesic for facilitating minor surgical and diagnostic procedures in horses.1-3

Domidine™ delivers the predictable, effective sedation veterinarians rely on while expanding access to a proven treatment option that supports both patient care and long-term practice success.

Trusted Worldwide for More Than a Decade
Domidine™ has been trusted by veterinarians globally for more than a decade and is established across Europe, the United Kingdom, Canada, and Mexico. Since 2016, more than 7 million* doses have been safely used globally, demonstrating its real-world performance and reliability.1-3

“Safe and effective sedation and analgesia is required daily in my sports medicine practice while doing diagnostic imaging, treating cases, facilitating clinical education and wet labs.” said Erik Bergman, DVM, Dipl. ECVSMR, Co-Founder and Managing Partner, SMDC Netherlands; Vice President, ISELP “That is why I trust Domidine™.”

Making Proven Sedation More Accessible
Domidine™ expands access to dependable equine sedation by offering veterinarians a cost-effective4 detomidine option that supports both clinical standards and long-term practice success.

“Veterinarians deserve the flexibility to choose the sedation protocol that best meets the needs of each horse and procedure,” said Dr. Greg Schmid, Equine Medical Affairs Lead, Dechra. “With more than 10 years of use in international markets, Domidine™ brings a well-established detomidine option to veterinarians in the United States, helping practices manage costs without compromising standards of care.”

Greater Choice, Proven Confidence
Backed by Dechra’s expertise in equine sedation, Domidine™ can be seamlessly integrated into existing sedation protocols. This launch reflects Dechra’s commitment to supporting equine practitioners with practical solutions for clinical and practice success.

Domidine™ provides an additional option within a familiar therapeutic category, enabling veterinarians to make treatment decisions based on patient and practice needs. “Whether practitioners are looking to maintain protocol consistency, optimize practice efficiency, or expand their sedation options, Domidine™ provides a reliable and proven choice,” said Schmid. “Our goal is to support veterinary teams with products and expertise that help them deliver exceptional care every day.”

A Trusted Partner in Equine Health
As a global leader in equine sedation, Dechra continues to provide practitioners with cost-effective4 solutions that combine trusted clinical performance and flexibility. For more information about Domidine™, veterinarians can contact their Dechra representative.

About Domidine™
Domidine™ is a generic version of detomidine, a potent alpha-2 agonist indicated for use as a sedative and analgesic in horses to facilitate minor surgical and diagnostic procedures. Domidine™ is backed by highly rated technical support and customer service, helping veterinarians confidently care for equine patients.1,5

Domidine™ Important Safety Information
As with all drugs, side effects may occur. Do not use Domidine Sterile Solution in horses with pre-existing atrioventricular (AV) or sinoatrial (SA) block, with severe coronary insufficiency, cerebrovascular disease, respiratory disease, or chronic renal failure. Intravenous potentiated sulfonamides should not be used in anesthetized or sedated horses. Careful consideration should be given to horses approaching or in endotoxic or traumatic shock, to horses with advanced liver or kidney disease, or to horses under stress from extreme heat, cold, fatigue, or high altitude. Do not use in horses intended for human consumption. Handle dosing syringes with caution to avoid direct exposure to skin, eyes or mouth. Refer to the prescribing information for complete details or visit www.dechra‐us.com.